EUVIMEDEUVIMED entdecken
Crossref

Design and evaluation of curcumin, naringenin, and alpha-lactalbumin encapsulated nanostructured lipid carriers for targeted ocular drug delivery in diabetic retinopathy

Pradip Nirbhavane, Anuja G Magar, Monika Nimse, Sharad S Kale, Shailesh S Chalikwar, Kailas K Moravkar

Experimental Eye Research · 2025

DOI: 10.1016/j.exer.2025.110520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2025. Verfasst von Pradip Nirbhavane und 5 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Pharmacy, Amity University Haryana, Gurugram, 122413, India. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Curcumin, Flavanones, Drug Delivery Systems. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Science and Engineering Research Board, Science for Equity, Empowerment and Development Division.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR), a leading cause of vision impairment and blindness, poses significant challenges for ocular drug delivery due to barriers limiting drug penetration to the eye's posterior segment. This study aimed to develop and characterize nanostructured lipid carriers (NLCs) encapsulating curcumin, naringenin, and alpha-lactalbumin for sustained and targeted ocular delivery via topical administration in DR management. The NLCs exhibited a uniform particle size of 138.7 ± 2.6 nm, high encapsulation efficiency (∼97 %), and a stable zeta potential of -25.6 mV. Transmission electron microscopy confirmed their spherical morphology, and differential scanning validated successful drug incorporation. In vitro studies demonstrated sustained release (82-86 % over 24 h), while ex vivo trans-corneal permeation using goat corneas showed effective drug penetration (67-73 % within 12 h). In vivo efficacy was assessed in a diabetic rat model over four weeks, where NLC-treated groups showed significant reduction in rat vitreous VEGF levels and preserved retinal morphology without signs of edema or hemorrhage. The NLC-based eye drop formulation demonstrated sustained drug release, enhanced trans-corneal drug permeation, and a significant reduction in vitreous VEGF levels, offering a promising, non-invasive therapeutic strategy for diabetic retinopathy and other posterior segment ocular disorders. Although retinal drug concentrations were not quantified in this study, pharmacodynamic outcomes support the formulation's potential efficacy; future studies will include pharmacokinetic profiling to further substantiate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyCurcuminFlavanonesDrug Delivery SystemsLipidsLactalbuminDrug CarriersNanostructuresAnimalsRatsDiabetes Mellitus, ExperimentalGoatsMaleRats, Sprague-DawleyMicroscopy, Electron, TransmissionVascular Endothelial Growth Factor AOphthalmic SolutionsCorneaVitreous BodyParticle Size

Stichwörter der Autor:innen

Diabetic retinopathyEye drop formulationNanostructured lipid carriersOcular drug deliverySustained releaseVEGF

Substanzen

CurcuminFlavanonesnaringeninLipidsLactalbuminDrug CarriersVascular Endothelial Growth Factor AOphthalmic Solutions

Autor:innen und Institutionen

  • Amity Institute of Pharmacy, Amity University Haryana, Gurugram, 122413, India.
  • School of Medicine, Hallym University, Chuncheon-si, 24252, Republic of Korea.
  • Department of Industrial Pharmacy and Quality Assurance, R. C. Patel Institute of Pharmaceutical Education and Research, Karwand Naka, Shirpur, Dhule, MS, 425405, India.
  • Department of Physiology, School of Medicine, Pusan National University, Yangsan, 50612, Gyeongsangnam-do, Republic of Korea.
  • Department of Industrial Pharmacy and Quality Assurance, R. C. Patel Institute of Pharmaceutical Education and Research, Karwand Naka, Shirpur, Dhule, MS, 425405, India. Electronic address: pharmashailesh@rediffmail.com.
  • Department of Industrial Pharmacy and Quality Assurance, R. C. Patel Institute of Pharmaceutical Education and Research, Karwand Naka, Shirpur, Dhule, MS, 425405, India; Regeron Inc., Chuncheon-si, Gangwon-do, 24232, Re…

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India
  • Science and Engineering Research Board
  • Science for Equity, Empowerment and Development Division

Zitieren

APA

Nirbhavane, P., Magar, A. G., Nimse, M., Kale, S. S., Chalikwar, S. S., & Moravkar, K. K. (2025). Design and evaluation of curcumin, naringenin, and alpha-lactalbumin encapsulated nanostructured lipid carriers for targeted ocular drug delivery in diabetic retinopathy. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110520

Vancouver

Nirbhavane P, Magar AG, Nimse M, Kale SS, Chalikwar SS, Moravkar KK. Design and evaluation of curcumin, naringenin, and alpha-lactalbumin encapsulated nanostructured lipid carriers for targeted ocular drug delivery in diabetic retinopathy. Experimental Eye Research. 2025. doi:10.1016/j.exer.2025.110520

BibTeX
@article{Nirbhavane2025,
  author = {Nirbhavane, Pradip and Magar, Anuja G and Nimse, Monika and Kale, Sharad S and Chalikwar, Shailesh S and Moravkar, Kailas K},
  title = {Design and evaluation of curcumin, naringenin, and alpha-lactalbumin encapsulated nanostructured lipid carriers for targeted ocular drug delivery in diabetic retinopathy},
  journal = {Experimental Eye Research},
  year = {2025},
  doi = {10.1016/j.exer.2025.110520}
}
Kostenlos starten →